Amoxicillin clavulanate potassium 875 mg

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy. There are no well-done studies that have been done in humans with amoxicillin. But in animal studies, pregnant animals were given this medication, and the babies did not show any medical issues related to this medication.

Tell your doctor if you are breastfeeding or plan to breastfeed.

Amoxicillin has been detected in human breast milk. Because of the possibility for adverse reactions in nursing infants from amoxicillin, a choice should be made whether to stop nursing or to stop use of this medication. The importance of the drug to the mother should be considered.

Amoxicillin comes as a capsule, tablet, and oral suspension forms. This medication is taken up to 3 times daily, with or without food. Thoroughly crush or chew and swallow the chewable tablets.

Do not chew, divide, or break regular amoxicillin tablets and capsules. If you miss a dose, take the missed dose as soon as you remember.

If it is almost time for the next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses of amoxicillin at the same time.

Take Amoxicillin exactly as prescribed by your doctor. Follow the directions on your amoxicillin and prednisone strep throat prescription label carefully. The Amoxicillin dose your doctor recommends will be based on the following: the condition being treated other medical conditions you have other medications you are taking how you respond to this medication your weight your height your age your gender. Neonates and Infants aged 12 weeks or younger (? 3 months): the recommended upper dose of amoxicillin is 30 mg/kg/day divided and given twice daily.

Adult Dosing (or children 40kg/88 lbs or greater): Ear/Nose/Throat infection, mild or moderate: 500 mg twice daily or 250 mg three times daily Ear/Nose/Throat, severe infection: 875 mg twice daily or 500 mg three times daily Lower respiratory tract (airway) infection, mild or moderate or severe: 875 mg twice daily or 500 mg three times daily Skin/Skin Structure infection, mild or moderate: 500 mg twice daily or 250 mg three times Skin/Skin Structure infection, severe: 875 mg twice daily or 500 mg three times daily Genitourinary tract infection, mild or moderate: 500 mg twice daily or 250 mg three times daily Genitourinary tract infection, severe: 875 mg twice daily or 500 mg three times daily Gonorrhea Acute, uncomplicated ano-genital and urethral infections in males and females: 3 grams as single oral dose. Dosing in Children (greater than 3 months old or less than 40 kg/88 lbs): Ear/Nose/Throat infection, mild or moderate: hours 25 mg/kg/day in divided doses every 12 hours or 20 mg/kg/day in divided doses every 8 hours Ear/Nose/Throat, severe infection: 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours Lower respiratory tract (airway) infection, mild or moderate or severe: 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours Skin/Skin Structure infection, mild or moderate: 25 mg/kg/day in divided doses every 12 hours or 20 mg/kg/day in divided doses every 8 hours Skin/Skin Structure infection, severe: 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours Genitourinary tract infection, mild or moderate: 25 mg/kg/day in divided doses every 12 hours or 20 mg/kg/day in divided doses every 8 hours Genitourinary tract infection, severe: 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every accord amoxicillin 8 hours Gonorrhea Acute, uncomplicated ano-genital and urethral infections in males and females: Prepubertal children: 50 mg/kg amoxicillin, combined with 25 mg/kg probenecid as a single dose.

SINCE PROBENECID IS CONTRAINDICATED IN CHILDREN UNDER 2 YEARS, DO NOT USE THIS REGIMEN IN THESE CASES. If you take too much amoxicillin, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.

Abclox Abimox-DC ACL Aclowell-L Acmox Acmox TAB Acmox-DS Actimox Adcil Adclox-D Afymox-DT Afymox-DX Agmox Agmox-DX Agmox-LB Alclox-D Aldico Alexi-DX Allmox Allmox INJ Allmox SYR Alnaclox Alnaclox-KID Alnaclox-LB Alnaclox-LB KID Alnamox Amclosym Amclox-DL Amdiclox Amex-D Amimox Amimox-DX Amo-DX Amoclox-D Amolac 250 Amolac 500 Amosis Amosis-DCL Amosym Amotex Amotex-D Amox Amox-AR Amox-DT Amox-LB Amoxil Amoxinga Amoxinga SYR Amoxipen Amoxivan. P - Caution when used during pregnancy L - Caution when used during lactation.

Amoxicillin abbreviated AMOX, is a moderate-spectrum, bacteriolytic, ?-lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms.

It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other ?-lactam antibiotics. Amoxicillin is susceptible to degradation by ?-lactamase-producing bacteria, and so may be given with clavulanic acid to decrease its susceptibility. Amoxicillin inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall by binding to one or more of the penicillin-binding proteins (PBPs), thus inhibiting cell wall biosynthesis resulting in bacterial lysis.

Absorption Rapidly and completely absorbed from the GI tract with peak plasma concentrations after 1-2 hours (oral). Not inactivated by gastric acid and presence of food does not impair absorption.

Distribution Widely distributed, CSF (small concentrations except when the meninges are inflamed), bile (high concentrations); crosses the placenta and enters the breast milk (small amounts).

Metabolism Converted to a limited extent to penicilloic acid.

Excretion Via the urine within 6 hours by glomerular filtration and tubular secretion (as penicilloic acid and 60% unchanged drug); via

the

May be removed by haemodialysis; 1-1.5 hours (elimination half-life). Amoxicillin Adverse Reactions / Amoxicillin Side Effects. Hyperactivity, agitation, insomnia, dizziness; maculopapular rash, exfoliative dermatitis, urticaria, hypersensitivity vasculitis; diarrhoea, nausea, vomiting; anaemia, thrombocytopenia, leucopenia, agranulocytosis.

Potentially Fatal: Neuromuscular hypersensitivity; pseudomembranous colitis.

Monitor Periodically assess renal, hepatic, and hematopoietic function during prolonged therapy. Patients diagnosed with gonorrhea should have a serologic test for syphilis at the time of treatment and a follow-up serologic test after 3 months. In the treatment of UTI, frequent bacteriological and clinical appraisals are necessary.

Renal and hepatic disease; pregnancy, lactation; infectious mononucleosis. Decreased effects with tetracyclines and chloramphenicol.

Potentially Fatal: Increase effects of oral anticoagulants.

Oral Endocarditis Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours. Child: ?10 years: 125-250 mg every 8 hours; Oral Biliary tract infections Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours.

Child: ?10 years: 125-250 mg every 8 hours; Oral Gonorrhoea Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours. Child: ?10 years: 125-250 mg every 8 hours: Oral Otitis media Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours Child: ?10 years: 125-250 mg every 8 hours; Oral Pneumonia Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours.

Child: ?10 years 125-250 mg every 8 hours; Oral Urinary tract infections Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hours.

Child: ?10 years: 125-250 mg every 8 hours; Oral Mouth infections Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours.

Child: ?10 years: 125-250 mg every 8 hours; Oral Spleen disorders Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours. Child: ?10 years: 125-250 mg every 8 hours; Oral Actinomycosis Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours. Child: ?10 years: 125-250 mg every 8 hours; Oral Bronchitis Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours.

Child: ?10 years: 125-250 mg every 8 hours; Oral Typhoid and paratyphoid fever Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours. Child: ?10 years: 125-250 mg every 8 hours; Oral Gastroenteritis Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours.

Child: ?10 years: 125-250 mg every 8 hours; Oral Lyme disease Adult: 250-500 mg every 8 hours or 500-875 mg every 12 hours.

Child: ?10 years: 125-250 mg every 8 hours; Oral Uncomplicated gonorrhoea Adult: 3 g as a single dose with probenecid 1 g. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hours and an additional dose during and after each dialysis session.

CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hours. Oral Dental abscesses Adult: Initially, 3 g, repeat once after 8 hours.

Oral Uncomplicated acute urinary tract infections Adult: Initially, 3 g, repeat once after 10-12 hours.

Oral Prophylaxis of endocarditis Adult: 2 or 3 g as a single dose, 1 hour before dental procedure.

Oral Severe or recurrent respiratory tract infections Adult: 3 g bid.

Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hours and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hours.

Oral Otitis media Child: 3-10 years: 750 mg bid for 2 days. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hours and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hours. Oral H.pylori infection Adult: 0.75 or 1 g bid or 500 mg tid in combination with either metronidazole or clarithromycin and a bismuth compound or an antisecretory drug.

Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hours and an additional dose during and after each dialysis session.

CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hours. Intravenous Listerial meningitis Adult: 2 g every 4 hours for 10–14 days via IV infusion, to be used with other antibiotics. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hours and an additional dose during and after each dialysis session.

CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hours. Parenteral Susceptible infections Adult: 500 mg every 8 hours via IM or slow IV injection.

Severe infections: May increase to 1 g every 6 hours via slow IV injection over 3-4 minutes or infuse over 30-60 minutes.

Child: ?10 years: 50-100 mg/kg daily in divided doses.

Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hours and an additional dose during and after each dialysis session.

CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hours. Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).

Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.

Listing a study does not mean it has been evaluated by the U.S.

Study Details Tabular View No Results Posted Disclaimer How to Read a Study Record.

Condition or disease Intervention/treatment Phase Periodontitis Procedure: SRP Other: Placebo Drug: MTZ+AMX Phase 4.

Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 58 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: Metronidazole and Amoxicillin as Adjuncts to Scaling and Root Planing for the Treatment of Type 2 Diabetic Subjects With Periodontitis: a Randomized Placebo-controlled Clinical Trial Study Start Date : September 2011 Estimated Primary Completion Date : October 2014 Estimated Study Completion Date : October 2014. Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.

To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information Ages Eligible for Study: 35 Years and older (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No.

? 35 years of age Diagnosis of type 2 DM for ? 5 years DM treatment with diet and insulin supplementation or oral hypoglycemic agents Glycated hemoglobin (HbA1c) levels ? 6.5% ? 11% At least 15 teeth More than 30% of the sites with probing depth (PD) and clinical attachment level (CAL) ? 4 mm Minimum of six teeth with at least one site with PD and CAL ? 5 mm and bleeding on probing (BoP) at baseline.

Pregnancy Lactation Current smoking Smoking within the past 5 years Scaling and root planing (SRP) in the previous 12 months Antimicrobial therapies during the previous 6 months Medical conditions requiring prophylactic antibiotic coverage Continuous use of mouthrinses containing antimicrobials in the preceding 3 months Systemic conditions (except DM) that could affect the progression of periodontitis (e.g.

immunological disorders, osteoporosis) Long-term administration of anti-inflammatory Long-term administration of immunosuppressive medications Allergy to metronidazole and/or amoxicillin Presence of periapical pathology Use of orthodontic appliances Presence of extensive prosthetic rehabilitation Major complications of DM (i.e.